Compare VBF & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VBF | SRZN |
|---|---|---|
| Founded | 1970 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.9M | 164.3M |
| IPO Year | N/A | N/A |
| Metric | VBF | SRZN |
|---|---|---|
| Price | $15.40 | $22.17 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 45.5K | ★ 149.5K |
| Earning Date | 01-01-0001 | 11-07-2025 |
| Dividend Yield | ★ 5.18% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,604,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.68 | $5.90 |
| 52 Week High | $16.27 | $24.94 |
| Indicator | VBF | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 45.03 | 54.20 |
| Support Level | $15.31 | $19.51 |
| Resistance Level | $15.46 | $23.37 |
| Average True Range (ATR) | 0.09 | 2.34 |
| MACD | 0.00 | 0.22 |
| Stochastic Oscillator | 38.89 | 53.67 |
Invesco Bond Fund is an independent investment management firm. Its investment objective is to seek interest income while conserving capital.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).